VARANESE, SARA
 Distribuzione geografica
Continente #
EU - Europa 1.013
NA - Nord America 979
AS - Asia 535
SA - Sud America 3
OC - Oceania 2
Totale 2.532
Nazione #
US - Stati Uniti d'America 976
CN - Cina 214
IT - Italia 206
UA - Ucraina 181
SG - Singapore 179
IE - Irlanda 155
GB - Regno Unito 116
TR - Turchia 98
FR - Francia 96
SE - Svezia 95
DE - Germania 85
FI - Finlandia 46
IN - India 40
RU - Federazione Russa 21
CH - Svizzera 5
BR - Brasile 3
IR - Iran 3
NL - Olanda 3
CA - Canada 2
NZ - Nuova Zelanda 2
CZ - Repubblica Ceca 1
LT - Lituania 1
MX - Messico 1
RO - Romania 1
SI - Slovenia 1
VN - Vietnam 1
Totale 2.532
Città #
Jacksonville 218
Chandler 200
Singapore 162
Dublin 154
Southend 107
Princeton 83
Nanjing 65
Izmir 63
Santa Clara 36
Cambridge 35
Wilmington 32
Nanchang 30
Beijing 23
Dearborn 22
Ashburn 20
Altamura 18
Grevenbroich 15
Rome 15
Milan 14
Shenyang 13
Helsinki 11
Munich 10
Boardman 9
Hebei 9
Kunming 9
Ann Arbor 8
Taizhou 8
Augusta 7
Changsha 7
Genova 6
Jiaxing 6
Jinan 6
Leawood 6
Los Angeles 6
Norwalk 6
London 5
Monmouth Junction 5
Shanghai 5
Tianjin 5
Changchun 4
Chiasso 4
Falls Church 4
Lanzhou 4
Ningbo 4
Appiano Gentile 3
Boretto 3
Caserta 3
Catania 3
Guangzhou 3
Nova Iguaçu 3
Sammichele di Bari 3
San Mateo 3
Washington 3
Zhengzhou 3
Aosta 2
Ardabil 2
Arezzo 2
Campobasso 2
Cesano Maderno 2
Clifton 2
Florence 2
Hangzhou 2
Houston 2
Mistretta 2
Mumbai 2
Napoli 2
New York 2
Nürnberg 2
Orange 2
Poggio Picenze 2
Porto Torres 2
Rovereto 2
Spoltore 2
Torino 2
Villanova Del Ghebbo 2
Alessandria 1
Andover 1
Antea 1
Auckland 1
Bangalore 1
Bari 1
Bologna 1
Candia Lomellina 1
Capua 1
Casoria 1
Casteldaccia 1
Chennai 1
Christchurch 1
Cornaredo 1
Dallas 1
Dolo 1
Edinburgh 1
Giugliano in Campania 1
Giulianova 1
Guardiagrele 1
Haikou 1
Hanoi 1
Hefei 1
Jesi 1
Jinhua 1
Totale 1.576
Nome #
La Mattis Dementia Rating Scale e la NPI messi al confronto nella valutazione della malattia di Alzheimer, demenza a corpi di Lewy diffusa e la malattia di Parkinson con Demenza, in una popolazione del centro Italia. 219
Bipallidal lesions induce delayed and progressive parkinsonism 94
Camptocormia nella Malattia di Parkinson e nella demenza a corpi di Lewy 85
EEG comparison in early AD, LBD, PDD patients with a 2 years follow-up. 81
Two novel POLG1 mutations in a patient with progressive external ophthalmoplegia, levodopa-responsive pseudo-orthostatic tremor and parkinsonism. 80
End-of-dose deterioration in non ergolinic dopamine agonist monotherapy of Parkinson's disease. 78
Camptocormia in Lewy Body disease (LBD) in comparison with Parkinson’s Disease (PD) 76
Fluctuating cognition and different cognitive and behavioural profiles in Parkinson's disease with dementia: comparison of dementia with Lewy bodies and Alzheimer's disease. 75
Camptocormia in Lewy Body Disease (LBD) in comparison with Parkinson’s Disease (PD). 74
Cortical rhythms in ad, LBD and normal subjects: A quantitative meg study 74
Irrelevant features of a stimulus can either facilitate or disrupt performance in a working memory task: The role of fluid intelligence. 73
PSI proteasome inhibitor induced rat model of Parkinson’s Disease. 73
Behavioural assessment of dysexecutive syndrome in Parkinson's disease without dementia: A comparison with other clinical executive tasks. 72
Cortical rhythms in ad, lbd and normal subjects: a quantitative MEG study 70
Protracted benefit from paradoxical kinesia in typical and atypical parkinsonisms. 69
Attention modulation regulates both motor and non-motor performance: a high-density EEg study in parkinson's disease 69
Clinical and electrohysiological analysis of the fluctuating cognition in patients affected by Dementia with Lewy Bodies. 68
Catamenial end-off dose in Parkinson's disease 67
EEG comparison in early AD, LBD, PDD patients with a 2-year follow-up 66
PSI induce proteasome inhibition and motor disturbances in rats 66
Acetyl-L-carnitine:from a biological curiosity to a drug for the peripheral nervous system and beyond. 65
Electrophysiological indices of interference resolution covary with individual fluid intelligence:investigating reactive control processes in 3-back working memory task. 65
Responsiveness of dysphagia to acute L-Dopa challenge in progressive supranuclear palsy 63
Un caso di sindrome disesecutiva in una paziente sottoposta ad STN-DBS: follow-up da 0 a 10 mesi 62
Camptocormia in Lewy body disease (LBD) in comparison with Parkinson's disease (PD) 62
Levetiracetam in patients with chronic epilepsy: the seizure outcome 61
Study of mitochondrial function in a psi-induced model of parkinson’s disease. 59
Cohort study of prevalence and phenomenology of tremor in dementia with Lewy bodies. 57
PSI produce l’inibizione del proteasoma causando disturbi motori in ratti 57
Incidence of RBD and hallucination in patients affected by Parkinson's disease 56
End –off dose catameniale nella malattia di Parkinson 50
Pathophysiology of Mental Disturbances in Parkinsonism 50
Hedonistic homeostatic dysregulation in Parkinson s Disease: Prevalence and incidence. Alzheimer’s and Parkinson’s disease: Insights, progress and perspectives 50
Botulinum toxin treatment of lateral axial dystonia in Parkinsonism 47
Pathophysiology of mental Disturbances in Parkinsonism 46
Pathophysiology of mental disturbances in parkinsonism 44
Modafinil and armodafinil improve attention and global mental status in Lewy bodies disorders: preliminary evidence 42
Totale 2.565
Categoria #
all - tutte 9.580
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.580


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020205 0 0 0 0 0 17 52 52 12 23 48 1
2020/2021242 39 5 39 2 8 44 6 7 26 33 31 2
2021/2022155 3 1 4 26 9 3 6 18 7 7 23 48
2022/2023544 45 72 40 40 52 109 34 35 85 6 9 17
2023/2024195 14 17 11 3 10 43 66 2 3 4 0 22
2024/2025332 32 155 115 3 8 19 0 0 0 0 0 0
Totale 2.565